Lung Cancer Trial, Recruiting (NCT07510321)

Lung Cancer Trial, Recruiting NCT07510321 Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Condition: Lung Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07510321 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Lung Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be able to sign a consent form yourself, or have someone legally allowed to sign it on your behalf.
You must be willing and able to follow all the steps and requirements of the study.
You must be 18 years old or older (any sex).
You must have a cancer that is either suspected or confirmed by a doctor, such as lung cancer, bowel cancer, or head and neck cancer, based on test results, scans, or tissue samples.
You must be in generally good overall health.
You must agree to allow the study team to use tissue samples that have already been collected.

Who may not be able to join:

People who are unable or unwilling to give their consent to take part.
People who are unable to follow the study's required procedures.
People who currently have a serious active illness affecting the whole body, or a significant imbalance in their body's minerals or salts (confirm with trial site).
Women who are pregnant or currently breastfeeding.
People who have any other condition that the study doctor feels makes participation unsuitable, for example, a known sensitivity or reaction to a specific type of cancer treatment called c-MET-targeted agents (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 30 June 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07510321

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase: Not Applicable

Status: Recruiting

Condition: Lung Cancer

More information: https://clinicaltrials.gov/study/NCT07510321

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be able to sign a consent form yourself, or have someone legally allowed to sign it on your behalf.
You must be willing and able to follow all the steps and requirements of the study.
You must be 18 years old or older (any sex).
You must have a cancer that is either suspected or confirmed by a doctor, such as lung cancer, bowel cancer, or head and neck cancer, based on test results, scans, or tissue samples.
You must be in generally good overall health.
You must agree to allow the study team to use tissue samples that have already been collected.

Who may not be able to join:

People who are unable or unwilling to give their consent to take part.
People who are unable to follow the study's required procedures.
People who currently have a serious active illness affecting the whole body, or a significant imbalance in their body's minerals or salts (confirm with trial site).
Women who are pregnant or currently breastfeeding.
People who have any other condition that the study doctor feels makes participation unsuitable, for example, a known sensitivity or reaction to a specific type of cancer treatment called c-MET-targeted agents (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 30 June 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Registry

ClinicalTrials.gov

Start date

27 November 2025

Est. completion

30 June 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Diagnostic Performance of [68Ga]Ga-FL-261 PET / [111In]In-FL-261 SPECT for Malignant Tumors

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov